Lichen planus

shabeelpn 28,546 views 33 slides Aug 07, 2009
Slide 1
Slide 1 of 33
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33

About This Presentation

No description available for this slideshow.


Slide Content

ORAL LICHEN PLANUSORAL LICHEN PLANUS
Dr shabeel pn
ROYAL DENTAL COLLEGE

Oral Lichen PlanusOral Lichen Planus
Common mucocutaneous disease with varying
clinical presentation
Wilson 1869
Lichen Ruber planus
Premalignant condition
Involvement of oral mucosa is frequent along
with or preceded by lesions on skin and genital
mucous membrane

DefinitionDefinition
OLP is a rather common chronic
mucocutaneous disease which probably
arises due to abnormal immunological
reaction and the disease have some tendency
to undergo malignant transformation

Lichenoid reactionsLichenoid reactions
Exhibits clinical and histological similarity
Distinguished from OLP on the basis of
1. association with administration of drug,
contact with a metal, use of
food flavors or systemic diseases
2. Resolution when the cause is eliminated or when
disease is treated

Epidemiology Epidemiology
Very common- 1% of population
In Indians 1.5%(average)
3.7% mixed oral habits
0.3% non users of tobacco
Risk more among who smoke and chew tobacco
cutaneous lesion alone 35%
mucosal lesion alone 25%
both together 40%

Etiology Etiology
Specific etiology is unknown
Psychological stress
No evident genetic bias or no uniform
etiologic factors
Abnormal recognition and expression of
basal keratinocytes of epithelium as
foreign antigens by langerhans cells

PathogenesisPathogenesis
CD8 + T cells trigger the apoptosis of oral epithelial
cells
They recognize an antigen which is similar to an
antigen associated with major histocompatability
complex class 1 on keratinocytes
They release cytokinins that attract additional
lymphocytes which accumulate in sub basilar
connective tissue
Liquefaction degeneration of basal keratinocytes

Clinical FeaturesClinical Features
Age- middle aged or elderly people
mean age of onset- 5
th
decade of life
rarely in young adults and children
More in females ( 1.4:1 )
Site- both skin lesions and mucosal
lesions are present
Grinspan’s syndrome –OLP, DM & HP

Skin LesionsSkin Lesions
Purple, pruritic and polygonal papules
May be discreet or gradually coalesce into plaques each
covered by fine glistering scale
Bilaterally symmetrical
Increase in size if subjected to any irritation
Usually self limiting unlike the oral lesions lasting only one
year or less
Initially red > purple or violaceous hue > a dirty brownish
color
Periods of regression and recurrence
“Koebner’s phenomenon”- skin lesions extend along the
areas of injury or irritation
Most often on wrist, forearms, knees, thighs and trunk
Face remains uninvolved

Mucosal LesionsMucosal Lesions
Normally asymptomatic
Bilaterally symmetrical
Sometimes simultaneously have OSF, leukoplakia,etc.
Clinical types
1.reticular
2.atrophic
3.erosive
4.bullous
5. other types

Reticular typeReticular type
Most common and most readily recognized
form
Slightly elevated fine whitish lines (Wickham’s
striae) in lace like or annular pattern
Lines are wavy and parallel
A tiny elevated dot like structure at the point of
intersection of lines
Commonly on buccal mucosa and buccal
vestibule
Sometimes on tongue, gingiva, lips and floor of
the mouth

Atrophic typeAtrophic type
Keratotic changes combined with
mucosal erythema
smooth, poorly defined erythematus
areas with or without peripheral striae
Usually associated with desquamative
gingivitis
Pain and burning sensation

Erosive typeErosive type
Pseudo membrane covered ulcerations with
keratosis and erythema
Severe form with extensive degeneration and
separation of epithelium from connective tissue
Faint white zone resembling radiating striae
seen at the junction with normal epithelium
Pain, burning sensation, bleeding,
desquamative gingivitis
Commonly on buccal mucosa and vestibule
More dysplasia and malignant transformation

Bullous typeBullous type
Vesciculobullous presentation combined with
reticular or erosive pattern
Rare form characterized by large vesicles or
bullae (4mm to 2cm)
Lesions usually develop within an erythematus
base, rupture immediately leaving painful
ulcers
Usually have peripheral radiating striae and
seen on posterior part of buccal mucosa

Other typesOther types
Plaque type: flattened white areas
-dorsal surface of tongue
-often resemble leukoplakia
Hypertrophic type: well circumscribed, elevated white lesion
resembling leukoplakia
-biopsy needed for diagnosis
Pigmented type: rarely erosive type can be associated with
diffused
-usually on buccal mucosa and vestibule
-reticulated white patches with or without a red erosive
component flanked brown macular foci

HistopathologyHistopathology
Hyper orthokeratinisation or hyper
parakeratinisation
Thickening of granular layer
Acanthosis of spinous layer
Intercellular oedema in spinous layer
“Saw-tooth” rete pegs
Liquefaction necrosis of basal layer- Max
Joseph spaces
Civatte ( hyaline or cytoid) bodies
Juxta epithelial band of inflammatory cells

Immunofluorescent StudiesImmunofluorescent Studies
Band of fibrinogen in the basement
membrane zone
Multiple IgM staining cytoid bodies in
dermal papilla or peribasalar area
Highly suggestive of lichen planus if
present in clusters

Differential DiagnosisDifferential Diagnosis
Lichenoid reactions
Leukoplakia
Candidiasis
Pemphigus
Cicatricial pemphigoid
Erythema multiforme
Syphilis
Recurrent aphthae
Lupus erythematosus
Squamous cell carcinoma

Malignant transformationMalignant transformation
Controversy
Increased risk of oral squamous cell
carcinoma
Frequency of transformation is low,
between 0.3% and 3%
Erosive and atrophic forms commonly
undergo transformation

TreatmentTreatment
No cure
Management of symptoms
Principal aims: resolution of painful symptoms,
resolution of mucosal lesions, reduction of risk of
cancer & maintenance of good oral hygiene
Corticosteroids: both systemic & topical
Topical:
0.05% fluocinonide ( Lidex)
0.05% clobetasol ( Temovate)
as pastes or gels
Candida overgrowth

ReferencesReferences
Burket’s Oral Medicine – 10
th
Edition
 Shafer’s Oral Pathology – 5
th
Edition
Essentials of Oral Pathology
www.emedicine.com
www.medscape.com